Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Avery Dennison Receives Positive Feedback and Increased Price Target from JP Morgan Analyst

Elaine Mendonca by Elaine Mendonca
February 1, 2024
in Breaking News
0
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

On February 1, 2024, Avery Dennison (NYSE:AVY) received positive feedback from JP Morgan analyst Jeffrey Zekaukas. Zekaukas maintained an “Overweight” rating on the company and increased the price target from $185 to $218. This aligns with the average one-year price target for Avery Dennison Corporation, which stands at $214.849. Various forecasts estimate the price to range between $186.85 and $261.45.

Avery Dennison Corporation has consistently demonstrated strong performance, earning an average rating of “outperform.” Notably, in 2009, J.P. Morgan upgraded the company from “Neutral” to “Overweight,” further solidifying its positive trajectory.

Avery Dennison Corporation (AVY) Stock Market Performance on February 1, 2024: Analysis and Considerations

On February 1, 2024, Avery Dennison Corporation (AVY) displayed a mixed performance in the stock market. AVY experienced a minor setback as the price of AVY shares decreased by $3.45, resulting in a 1.73% drop from the previous market close.

AVY started the day at $200.72, opening $1.27 higher than its previous close. However, as the trading day progressed, AVY faced selling pressure, leading to a decline in its share price.

Despite the drop, AVY’s performance should be viewed in the context of its overall market standing. Trading near the top of its 52-week range suggests that the stock has been performing well compared to its historical performance. Additionally, being above its 200-day simple moving average indicates a bullish trend in the stock’s price.

Investors should consider various factors when analyzing AVY’s performance on February 1, 2024. The decrease in share price could be attributed to profit-taking by investors who had seen a recent increase in AVY’s value. Market conditions and broader economic factors may have also influenced the stock’s performance.

It is important to note that stock market performance can be volatile, and a single day’s performance may not be indicative of the stock’s long-term trajectory. Investors should conduct thorough research and analysis, considering both technical and fundamental factors, before making any investment decisions.

As always, it is recommended to consult with a financial advisor or professional before making any investment choices.

AVY Stock Performance on February 1, 2024: Revenue and Net Income Decline, but EPS Shows Potential Recovery

AVY Stock Performance on February 1, 2024:

Total revenue for AVY in the past year stood at $8.36 billion, reflecting a decrease of 7.47% compared to the previous year. However, it is worth noting that the company managed to hold its revenue flat since the last quarter.

Moving on to net income, AVY reported a figure of $503 million for the past year, representing a decline of 33.56% compared to the previous year. Similar to the revenue trend, AVY was able to hold its net income flat since the last quarter.

Earnings per share (EPS) is another crucial metric to consider when evaluating a company’s stock performance. AVY reported an EPS of $6.20 for the past year, which is a decrease of 32.66% compared to the previous year. However, there was a slight improvement in EPS since the last quarter, with a 3.47% increase.

Overall, AVY’s stock performance on February 1, 2024, exhibited a mixed bag of results. While total revenue and net income experienced declines compared to the previous year, the company was able to stabilize these figures since the last quarter. Additionally, the slight increase in EPS since the last quarter indicates a potential recovery in profitability per share.

Investors should consider a comprehensive analysis of various factors before making any investment decisions.

Tags: AVY
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Title IGC Pharmas TGR63 Shows Promise in Halting Alzheimers Progression

Ashland Receives Underweight Rating from JP Morgan Analyst

Sanofi Reports Positive Revenue Growth and Focus on Biopharmaceuticals

Recommended

Warner Bros. Discovery (A) Stock

Acquisition Battle Intensifies for Warner Bros. Discovery

3 months ago
Reviva Pharmaceuticals Holdings Stock

Reviva Pharmaceuticals Stock Surges on Extraordinary Trading Activity

4 months ago
MMM stock news

Analyst Insights and Price Targets for BILL Holdings

2 years ago
IonQ Stock

IonQ Shares Experience Technical Breakthrough Amid Market Correction

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

DroneShield Shares Face Headwinds Despite Record Performance

Rock Tech Lithium: Investors Await the Final Go-Ahead

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Trending

Chicago Atlantic Real Estate Finance Stock
Analysis

Tax Clarity and Sector Optimism Bolster Outlook for Chicago Atlantic

by SiterGedge
February 8, 2026
0

Investors in Chicago Atlantic Real Estate Finance have received welcome clarification regarding the tax treatment of the...

RBB Stock

RBB Bancorp Reports Strong Asset Quality Improvement and Strategic Capital Review

February 8, 2026
Cassava Sciences Stock

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

February 8, 2026
DroneShield Stock

DroneShield Shares Face Headwinds Despite Record Performance

February 8, 2026
Rock Tech Lithium Stock

Rock Tech Lithium: Investors Await the Final Go-Ahead

February 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Tax Clarity and Sector Optimism Bolster Outlook for Chicago Atlantic
  • RBB Bancorp Reports Strong Asset Quality Improvement and Strategic Capital Review
  • Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com